December 2023
1. 
   Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study.
   Lancet. 2023 Dec 12:S0140-6736(23)01842-1. doi: 10.1016/S0140-6736(23)01842.
   

   >> Share

   
   
2. MCGOWAN MP, Cuchel M
   Universal paediatric screening for familial hypercholesterolaemia.
   Lancet. 2023 Dec 12:S0140-6736(23)02182-7. doi: 10.1016/S0140-6736(23)02182.
   

   >> Share

   
   November 2023
3. AYOUB A, Akyea RK, L'Esperance V, Ayis S, et al
   Determinants of lipid clinic referral and attendance in a multi-ethnic adult population in south London: a cross-sectional study.
   Lancet. 2023;402 Suppl 1:S26.
   

   >> Share

   
   September 2023
4. MANSFIELD BS, Raal FJ
   Regression of cutaneous xanthomata in patient with homozygous familial hypercholesterolemia using novel therapies.
   Lancet. 2023;402:e11.
   

   >> Share

   
   March 2023
5. RIDKER PM, Bhatt DL, Pradhan AD, Glynn RJ, et al
   Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials.
   Lancet. 2023 Mar 3:S0140-6736(23)00215-5. doi: 10.1016/S0140-6736(23)00215.
   

   >> Share

   
   January 2023
6. MURAI K, Fujino M, Harada-Shiba M, Yasuda S, et al
   Spontaneous rupture of Achilles tendon xanthomas in a case of familial hypercholesterolaemia.
   Lancet. 2023;401:140.
   

   >> Share

   
   July 2022
7. ABUSHAMAT LA, Ballantyne CM
   Lowering LDL cholesterol in clinical practice: time for change?
   Lancet. 2022;400:341-343.
   

   >> Share

   
   January 2022
8. SANCHEZ-HERNANDEZ RM, Civeira F
   Homozygous familiar hypercholesterolemia: still a long way to go.
   Lancet. 2022 Jan 28. pii: S0140-6736(21)02223.
   

   >> Share

   
   
9. TROMP TR, Hartgers ML, Hovingh GK, Vallejo-Vaz AJ, et al
   Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study.
   Lancet. 2022 Jan 28. pii: S0140-6736(21)02001.
   

   >> Share

   
   September 2021
10. 
    Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC).
    Lancet. 2021 Sep 7. pii: S0140-6736(21)01122.
    

    >> Share

    
    
11. CUCHEL M, McGowan MP
    Familial hypercholesterolaemia: too many lost opportunities.
    Lancet. 2021 Sep 7. pii: S0140-6736(21)01372.
    

    >> Share

    
    March 2021
12. FIGTREE GA, Vernon ST, Hadziosmanovic N, Sundstrom J, et al
    Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data.
    Lancet. 2021;397:1085-1094.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share